Str Strate tegies gies for Enga or Engaging ging Sta State te - - PowerPoint PPT Presentation

str strate tegies gies for enga or engaging ging
SMART_READER_LITE
LIVE PREVIEW

Str Strate tegies gies for Enga or Engaging ging Sta State te - - PowerPoint PPT Presentation

Str Strate tegies gies for Enga or Engaging ging Sta State te Medicaid to Medicaid to Expand Expand Tobacc obacco Cessa o Cessation Ef tion Effor orts ts Tue uesd sday ay, , Apr pril il 16 16, , 20 2019 19 3:00 3:00-4:00


slide-1
SLIDE 1

Str Strate tegies gies for Enga

  • r Engaging

ging Sta State te Medicaid to Medicaid to Expand Expand Tobacc

  • bacco Cessa
  • Cessation Ef

tion Effor

  • rts

ts

Tue uesd sday ay, , Apr pril il 16 16, , 20 2019 19 3:00 3:00-4:00 4:00pm pm ET ET

slide-2
SLIDE 2

Today’s Presenters

Joe Parks, MD Medical Director National Council for Behavioral Health Cherline Gene, MSW Program Coordinator, Bureau of Community Health and Prevention Massachusetts Department of Public Health Janet Noonan, MS, M-TTS Cessation Program Coordinator , Bureau of Community Health and Prevention Massachusetts Department of Public Health

slide-3
SLIDE 3

People eople with mental with mental and substance and substance use use disor disorder ders: s:

  • Are approximately twice as likely as the general population

to smoke cigarettes,1

  • Are more likely to die from smoking-related illness than

from their mental and substance use disorders (i.e. behavioral health conditions),2,3 and

  • Want to quit smoking and are able to do so successfully,

which both reduces their risk of developing smoking- related diseases and may also improve their behavioral health outcomes.4,5,6

slide-4
SLIDE 4
  • 48.6% had a smoke-free campus,
  • 48.9% screened clients for tobacco use,
  • 37.6% offered tobacco cessation counseling,
  • 25.2% offered nicotine replacement therapy (NRT)
  • 21.5% offered non-nicotine tobacco cessation

medications.7

In 201 In 2016, 6, amon among U g U.S. .S. mental mental health health ser services vices tr trea eatment tment facilities: acilities:

slide-5
SLIDE 5
  • 34.5% had smoke-free campuses,
  • 64.0% screened clients for tobacco use,
  • 47.4% offered tobacco cessation counseling,
  • 26.2% offered NRT,
  • 20.3% offered non-nicotine tobacco cessation

medications

In 2016, among U In 2016, among U.S. .S. substance use substance use disor disorder der tr trea eatment tment facilities: acilities:

slide-6
SLIDE 6

Str Strate tegy y 1: Lear 1: Learn Y n Your Sta

  • ur States

tes Benefit Benefit

  • Coverage is often better than people assume
  • Google search your state Medicaid pharmacy and

counseling service benefits.

  • Search by both state agency and contracted

Medicaid managed care plan. Key words:

– “State” Medicaid tobacco cessation benefit – “MCO name” Tobacco cessation benefit – “State” Medicaid or “MCO name” Pharmacy nicotine replacement – “State” Medicaid or “MCO name” Pharmacy varenicline

slide-7
SLIDE 7

Str Strate tegy y 1: Lear 1: Learn Y n Your Sta

  • ur States

tes Benefit Benefit

  • Many Medicare part D pharmacy benefit plans cover

medications for nicotine cessation

  • Use the Medicare formulary finder to identify which

Medicare D Plans available in your state cover nicotine replacement products and varenicline

  • https://www.medicare.gov/find-a-

plan/questions/home.aspx

slide-8
SLIDE 8

Bupropion

  • Commonly prescribed generic mostly used as a

antidepressant

  • As effective for smoking cessation as varenicline
  • Even more effective in combination with varenicline
  • Marketed as:

– Bupropion (generic name) – Wellbutrin – Zyban

The S he Smokin moking Cessa g Cessati tion

  • n Medica

Medicati tion

  • n

Tha hat Ev t Ever ery y Plan Plan Co Cover ers

slide-9
SLIDE 9
  • Define Smoking cessation conversations as

allowable Content for:

– Psychosocial Rehab and Psychoeducation – SUD counseling

  • Section 2703 Health Homes for Chronic Conditions

– Health Promotion Service – PMPM payment

  • Certified Community Behavioral Health Center

– PPS

  • Prescriber E&M codes

Co Cover erage ge Outside of Outside of Smoking Smoking Ces Cessa sation Specific Cod tion Specific Codes es

slide-10
SLIDE 10

Str Strate tegy y 2: 2: De Develop elop a Str a Strong P

  • ng Par

artner tnership ship with the rig with the right people to ht people to enhance or ada enhance or adapt pt the benefit the benefit as/if as/if needed. needed.

slide-11
SLIDE 11

Key decision ey decision-mak maker ers

  • Individuals

– Medicaid Director – Medicaid Pharmacy Director – Medicaid Medical Director

  • Committees

– Medicaid Pharmacy Prior Authorization Committee – Medicaid Pharmacy Drug Utilization Review Committee – Medicaid Advisory Committee

slide-12
SLIDE 12
  • Including

– Individual, group, and telephone counseling – The seven FDA-approved cessation medications

  • Removing barriers

– Copayments, – Prior authorization, – Limits on the number of treatments allowed per year – Limits on how long treatment can be provided

Wor

  • rking

king wi with th sta state te Medicaid Medicaid pr prog

  • grams

ams to to co cover er evide videnc nce-base based d cess cessation tion tr trea eatm tmen ents ts

slide-13
SLIDE 13
  • State Mental Health Authority
  • State Dept of Health
  • Provider Associations
  • Medical Societies and Nursing Associations
  • NAMI, MHA, and other Advocacy Groups
  • Peer Specialists – especially ex-smokers

Other I Other Impor mportant P tant Par artner tners

slide-14
SLIDE 14

Par artner tnership Principles ship Principles

DON’T

  • Talk about your need first
  • Expect to get something
  • Limit assistance to a

project

  • Make it about this deal
  • Push a specific position
  • Withhold information
  • Let them take their lumps

DO DO

  • Ask about their needs

first

  • Give something
  • Assist wherever you can
  • Make it about the next 10
  • Pursue common interest
  • Reveal anything helpful
  • Take one for the team
slide-15
SLIDE 15

Str Strate tegy y 3: 3: Communica Communicate te the the Benefit (Cr Benefit (Crea eate a R te a Resour esource) ce)

  • For your State Medicaid FFS pharmacy and/or each

Medicaid MCO create a one Pager listing:

– Tobacco cessation counseling codes covered – FDA-approved cessation medications – Treatment limitations for each

  • For each subsidized Medicaid Part Plan in your state

create a one Pager listing:

– Tobacco cessation counseling codes covered – FDA-approved cessation medications – Treatment limitations for each

slide-16
SLIDE 16

Str Strate tegy y 4: Enhance the 4: Enhance the Use of Use of the Ben the Benefit efit

  • Train Providers on the 5 As
  • Most Important Messages

– People with MI and SUD want to quit smoking – People with MI and SUD can quit smoking

  • Disseminate Benefit Resource Sheets
  • Train Prescribers on prescribing NRTs, varenicline,

and bupropion for Tobacco Cessation

  • Benchmark prescribers and provider organizations on

utilization of tobacco cessation counseling billing codes and tobacco cessation medications

  • Publicly share and discuss the benchmark reports
slide-17
SLIDE 17

"5 A's "5 A's": ": Ask, Advise, Asses Ask, Advise, Assess, s, Ass Assist, ist, and Ar and Arrange. ange.

  • Ask - Identify and document tobacco use status for

every patient at every visit.

  • Advise

vise - In a clear, strong, and personalized manner, urge every tobacco user to quit.

  • Asse

sess ss - Is the tobacco user willing to make a quit attempt at this time?

  • Assis

sist - For the patient willing to make a quit attempt, use counseling and pharmacotherapy to help him or her quit.

  • Arra

rang nge - Schedule follow-up contact, in person or by telephone, preferably within the first week after the quit date.

slide-18
SLIDE 18
slide-19
SLIDE 19

Bar Barrier riers

  • Not knowing Smoking Cessation Benefit Coverage
  • Believing that persons with MI and SUD don’t want

to and cannot quit

  • Not implementing the 5 As
  • Myth that varenicline causes depression/suicide

– THIS IS NOT TRUE – “Varenicline Should Be Used as a First-Line Treatment to Help Smokers with Mental Illness Quit” – JOURNAL OF DUAL DIAGNOSIS, 8(2), 113–116, 2012

slide-20
SLIDE 20

Work With Your Partners

  • Remove barriers

– Copayments, – Prior authorization, – Limits on the number of treatments allowed per year – Limits on how long treatment can be provided

  • Enhance Coverage outside of Smoking Cessation

specific codes

  • Training, training, more training
  • Measure process and outcome performance

– Benchmark prescribers and organizations – Publicly discuss results

Sustaina Sustainability bility

slide-21
SLIDE 21
slide-22
SLIDE 22

Resour esources ces

  • CDC resource providing examples of promising

policies and practices from several states that are addressing tobacco use by persons with mental and substance use disorders.

– https://www.cdc.gov/tobacco/disparities/promising- policies-and-practices/index.html.

slide-23
SLIDE 23

Mass MassHealth Health

slide-24
SLIDE 24

Ov Over erview view of

  • f Ma

MassHealth ssHealth

  • Combined Medicaid and Children’s Health

Insurance Program

  • Covers nearly 1.9 million people in MA
  • State spending on MassHealth comprises 24%
  • f the state funds in budget
  • “1115 Waiver” – 5-year agreement (2018-

2022) with federal Centers for Medicare and Medicaid Services (CMS) on how to restructure MassHealth

slide-25
SLIDE 25

Funding Stream Key Elements Accountable Care Organization (60 %)

  • Network of providers with shared medical

and financial responsibility to coordinate patient care with the goal of: improve health, increase quality, and reduce costs Community Partners (30%)

  • Responsible for care management and

coordination for populations with significant behavioral health needs

  • Actively outreach and engage

individuals/families

  • Assess needs, provide options and refer

to services

  • Coordinate with individual and

providers to develop and maintain a care plan

  • Help navigate medical , behavioral

health, disability, social services Statewide Investments (6%)

  • Workforce development and training
  • Technical assistance to ACOs and BHCPs

Implementation/Oversight (4%)

  • Implementation and operations
  • Oversight
slide-26
SLIDE 26

Key Succ ey Success esses in Enga es in Engaging ging Mass MassHealth Health

Legislation

  • 2006 MA Health Care Reform – state mandate a

MassHealth tobacco cessation benefit

Collaboration and Promotion

  • MTCP and MassHealth collaborate to promote availability
  • f cessation benefit through mass media campaign

Evaluating Impact

  • Pilot study to evaluate cessation benefit to members

Continuous Improvement

  • CDC 6I18 Initiative- improving cessation services
slide-27
SLIDE 27

Ret etur urn n on

  • n In

Inves estme tment nt on

  • n Expa

Expand nded ed Mas MassHe sHealth alth Ben Benefit efit

Researchers performed a Return of Investment (ROI) analysis associated with reductions in-patient hospital admissions for cardiovascular conditions as a result of the Expanded Medicaid Cessation Benefit from 2007-2009. Researchers analyzed program costs (medication benefit, promotion and outreach of the benefit) and the short-term ROI. After beginning to use smoking cessation medications, MassHealth beneficiaries experienced fe fewer r hospita tal admissions ns due to cardiovascular conditions

Background Methods Results

Each $1 dollar spent on medications, counseling, or promotion of the benefit was associated with a reduction of $3.12 in MassHealth expenditures for cardiovascular hospital admissions, for a net savings

  • f $2.12

12

This was realized an average of 1.3 years after receiving cessation treatment.

For every $1 dollar spent We see a ROI of $2.12

27

slide-28
SLIDE 28

Key ey Challenges/Bar Challenges/Barrier riers in in Enga Engaging MassH ging MassHealth ealth

  • MassHealth restructuring process
  • Competing health mandates
  • Addressing gaps and barriers to cessation

services

  • Staff turnover
slide-29
SLIDE 29

Futur Future e plans plans with MassHealth and with MassHealth and anticipa anticipated enga ted engagement gement str strate tegies gies

  • Collaborate with Behavioral Health Community Partners

(BHCPs) to: ➢ Provide staff training ➢ Facilitate systems change that strengthen and/or implement tobacco treatment and referrals

  • Present at ACO and BHCP leadership meetings to increase

knowledge of tobacco cessation strategies and make the case for investing in cessation

  • Educate stakeholders to address “Carve out”
slide-30
SLIDE 30
slide-31
SLIDE 31